About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 642 entries already.
Entries by Max
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- UPDATE: Phase 1 Trial for RAD 402 Dosed the First Patient April 1, 2026
- Phase 1 Trial: Dual-Target ADC IDE034 Targets B7-H3/PTK7 in Prostate Cancer April 1, 2026
- New Xaluritamig (AMG 509) Monotherapy Phase 1 Trial for mCRPC March 31, 2026
- UPDATE: MRT-2359 in Metastatic Castration-Resistant Prostate Cancer March 30, 2026